ANTARES PHARMA, INC. Insider Trading for December 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ANTARES PHARMA, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ANTARES PHARMA, INC. for December 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 26 2019 | ATRS | ANTARES PHARMA, IN ... | SAMSON MARVIN | Director | Option Exercise | M | 1.12 | 150,000 | 168,000 | 0 | |
| Dec 26 2019 | ATRS | ANTARES PHARMA, IN ... | SAMSON MARVIN | Director | Sell | S | 4.71 | 150,000 | 706,500 | 51,751 | 201.8 K to 51.8 K (-74.35 %) |
| Dec 26 2019 | ATRS | ANTARES PHARMA, IN ... | SAMSON MARVIN | Director | Buy | M | 1.12 | 150,000 | 168,000 | 201,751 | 51.8 K to 201.8 K (+289.85 %) |
| Dec 11 2019 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Option Exercise | M | 1.66 | 40,000 | 66,400 | 0 | |
| Dec 11 2019 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Option Exercise | M | 1.60 | 40,000 | 64,000 | 0 | |
| Dec 11 2019 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Sell | S | 4.58 | 40,000 | 183,236 | 194,186 | 234.2 K to 194.2 K (-17.08 %) |
| Dec 11 2019 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Buy | M | 1.66 | 40,000 | 66,400 | 234,186 | 194.2 K to 234.2 K (+20.60 %) |
| Dec 11 2019 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Sell | S | 4.58 | 40,000 | 183,236 | 194,186 | 234.2 K to 194.2 K (-17.08 %) |
| Dec 11 2019 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Buy | M | 1.60 | 40,000 | 64,000 | 234,186 | 194.2 K to 234.2 K (+20.60 %) |
| Dec 11 2019 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Option Exercise | M | 1.66 | 80,000 | 132,800 | 0 | |
| Dec 11 2019 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Option Exercise | M | 1.60 | 80,000 | 128,000 | 0 | |
| Dec 11 2019 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Sell | S | 4.63 | 84,814 | 392,833 | 212,749 | 297.6 K to 212.7 K (-28.50 %) |
| Dec 11 2019 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Sell | S | 4.62 | 80,000 | 369,776 | 297,563 | 377.6 K to 297.6 K (-21.19 %) |
| Dec 11 2019 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Buy | M | 1.66 | 80,000 | 132,800 | 377,563 | 297.6 K to 377.6 K (+26.89 %) |
| Dec 11 2019 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Sell | S | 4.63 | 80,000 | 370,536 | 297,563 | 377.6 K to 297.6 K (-21.19 %) |
| Dec 11 2019 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Buy | M | 1.60 | 80,000 | 128,000 | 377,563 | 297.6 K to 377.6 K (+26.89 %) |
| Dec 11 2019 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Option Exercise | M | 3.96 | 58,524 | 231,755 | 0 | |
| Dec 11 2019 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Option Exercise | M | 3.96 | 1,000 | 3,960 | 0 | |
| Dec 11 2019 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Option Exercise | M | 2.94 | 110,000 | 323,400 | 0 | |
| Dec 11 2019 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Option Exercise | M | 1.66 | 97,000 | 161,020 | 0 | |
| Dec 11 2019 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Option Exercise | M | 1.52 | 100,000 | 152,000 | 0 | |
| Dec 11 2019 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Sell | S | 4.76 | 58,524 | 278,358 | 1,905,891 | 2 M to 1.9 M (-2.98 %) |
| Dec 11 2019 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Buy | M | 3.96 | 58,524 | 231,755 | 1,964,415 | 1.9 M to 2 M (+3.07 %) |
| Dec 11 2019 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Sell | S | 4.75 | 1,000 | 4,750 | 1,905,891 | 1.9 M to 1.9 M (-0.05 %) |
| Dec 11 2019 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Buy | M | 3.96 | 1,000 | 3,960 | 1,906,891 | 1.9 M to 1.9 M (+0.05 %) |
| Dec 11 2019 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Sell | S | 4.58 | 110,000 | 503,426 | 1,905,891 | 2 M to 1.9 M (-5.46 %) |
| Dec 11 2019 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Buy | M | 2.94 | 110,000 | 323,400 | 2,015,891 | 1.9 M to 2 M (+5.77 %) |
| Dec 11 2019 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Sell | S | 4.62 | 97,000 | 448,412 | 1,905,891 | 2 M to 1.9 M (-4.84 %) |
| Dec 11 2019 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Buy | M | 1.66 | 97,000 | 161,020 | 2,002,891 | 1.9 M to 2 M (+5.09 %) |
| Dec 11 2019 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Sell | S | 4.68 | 100,000 | 467,830 | 1,905,891 | 2 M to 1.9 M (-4.99 %) |
| Dec 11 2019 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Buy | M | 1.52 | 100,000 | 152,000 | 2,005,891 | 1.9 M to 2 M (+5.25 %) |